Minimally immunogenic decellularized porcine valve provides in situ recellularization as a stentless bioprosthetic valve
Tóm tắt
Currently used bioprosthetic valves have several limitations such as calcification and functional deterioration, and revitalization through cellular ingrowth is impossible. To overcome these obstacles, we have developed a minimally immunogenic tissue-engineered valve that consists of an unfixed, decellularized porcine valve scaffold capable of being spontaneously revitalized in vivo after implantation. Porcine aortic root tissue was decellularized using detergents such as sodium lauryl sulfate and Triton X-100. The porcine valve was treated very gently and plenty of time was allowed for constituents to diffuse in and out of the matrix. In a preliminary study, a piece of decellularized porcine valve tissue was implanted into the rat subdermal space for 14 and 60 days and the structural integrity and calcification were evaluated. As an in vivo valve replacement model, the decellularized porcine valve was implanted in the pulmonary valve position in dogs and functional and histological evaluation was performed after 1, 2, and 6 months. Histological examination showed that the newly developed detergent treatment effectively removed cellular debris from the porcine aortic tissue. Decellularized porcine valve tissue implanted subdermally in rats showed minimal inflammatory cell infiltration and calcification. In the valve replacement model, spontaneous reendothelialization and repopulation of the medial cells were observed within 2 months, and good valve function without regurgitation was observed by echocardiography up to 6 months. The minimally immunogenic decellularized porcine valve proved effective in mitigating postimplant calcification and provided a suitable matrix for revitalizing prostheses through in situ recellularization, cellular ingrowth, and tissue remodeling.
Tài liệu tham khảo
WJ Flameng S Ozaki J Yperman P Herijgers B Meuris AV Lommel E Verbeken (2001) ArticleTitleCalcification characteristics of porcine stented valves in a juvenile sheep model Ann Thorac Surg 71 S401–405 Occurrence Handle11388234 Occurrence Handle10.1016/S0003-4975(01)02527-9 Occurrence Handle1:STN:280:DC%2BD3MzhsVynug%3D%3D
A Bader T Schilling OE Teebken G Brandes T Herden Steinhoff A Haverich (1998) ArticleTitleTissue engineering of heart valves: human endothelial cell seeding in detergent acellularized porcine valves Eur J Cardiovasc Surg 14 279–284 Occurrence Handle10.1016/S1010-7940(98)00171-7 Occurrence Handle1:STN:280:DyaK1cvjt1Kjtw%3D%3D
MF O'Brien S Goldstein S Walsh KS Black R Elkins D Clarke (1999) ArticleTitleThe SynerGraft valve: a new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization – first experimental studies before clinical implantation Semin Thorac Cardiovasc Surg 11 194–200 Occurrence Handle10660192
PM Dohmen A Lembcke H Hotz D Kivelitz WF Konertz (2002) ArticleTitleRoss operation with tissue-engineered heart valve Ann Thorac Surg 74 1438–1442 Occurrence Handle12440590 Occurrence Handle10.1016/S0003-4975(02)03881-X
RJ Levy FJ Schoen JT Levy AC Nelson SL Howard LJ Oshry (1998) ArticleTitleBiologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats Am J Pathol 113 143–155
E Rieder MT Kasimir G Silberhumer G Seebacher E Wolner P Simon G Weigel (2004) ArticleTitleDecellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells J Thorac Cardiovasc Surg 127 399–405 Occurrence Handle14762347 Occurrence Handle10.1016/j.jtcvs.2003.06.017
E Rieder G Seebacher MT Kasimir E Eichmair B Winter B Dekan E Wolner P Simon G Weigel (2005) ArticleTitleTissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells Circulation 111 2792–2797 Occurrence Handle15911701 Occurrence Handle10.1161/CIRCULATIONAHA.104.473629
P Simon MT Kasimir G Seebacher G Weigel R Ullrich U Salzer-Muhar E Rieder E Wolner (2003) ArticleTitleEarly failure of the tissue engineered porcine heart valve Synergraft in pediatric patients Eur J Cardiothorac Surg 23 1002–1006 Occurrence Handle12829079 Occurrence Handle10.1016/S1010-7940(03)00094-0 Occurrence Handle1:STN:280:DC%2BD3szgtFGjuw%3D%3D
S Iwai Y Sawa H Ichikawa S Taketani E Uchimura G Chen M Hara J Miyake H Matsuda (2004) ArticleTitleBiodegradable polymer with collagen microsponge serves as a new bioengineered cardiovascular prosthesis J Thorac Cardiovasc Surg 128 472–479 Occurrence Handle15354111 Occurrence Handle10.1016/j.jtcvs.2004.04.013 Occurrence Handle1:CAS:528:DC%2BD2cXosFyktr8%3D
S Iwai Y Sawa S Taketani K Torikai H Koichiro H Matsuda (2005) ArticleTitleNovel tissue-engineered biodegradable material for reconstruction of vascular wall Ann Thorac Surg 80 1821–1828 Occurrence Handle16242461 Occurrence Handle10.1016/j.athoracsur.2005.03.139
T Asahara H Masuda T Takahashi C Kalka C Pastore M Silver M Kearne M Magner JM Isner (1999) ArticleTitleBone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological neovascularization Circ Res 85 IssueID3 221–228 Occurrence Handle10436164 Occurrence Handle1:CAS:528:DyaK1MXltFGgs7Y%3D
Q Shi S Rafii MH Wu ES Wijelath C Yu A Ishida Y Fujita S Kothari R Mohle LR Sauvage MAS Moore RF Storb WP Hammond (1998) ArticleTitleEvidence for circulating bone marrow-derived endothelial cells Blood 92 IssueID2 362–367 Occurrence Handle9657732 Occurrence Handle1:CAS:528:DyaK1cXksFarur4%3D
S Ota Y Sawa S Iwai T Kitajima Y Ueda CM Coppin H Matsuda Y Okita (2005) ArticleTitleFibronectin-hepatocyte growth factor enhances reendothelialization in tissue-engineered heart valve Ann Thorac Surg 80 1794–1802 Occurrence Handle16242457 Occurrence Handle10.1016/j.athoracsur.2005.05.002